{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:48:49Z","timestamp":1778712529421,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The synthetic glucocorticoid dexamethasone (DEX) is commonly used to prevent chronic lung disease in prematurely born infants. Treatment regimens usually consist of high doses of DEX for several weeks, notably during a critical period of brain development. Therefore, there is some concern about adverse effects of this clinical practice on fetal brain development. In this study, using a clinically relevant rat model, we examined the impact of neonatal DEX treatment on subsequent brain injury due to an episode of cerebral hypoxia-ischemia (HI).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We found that a 3-day tapering course (0.5, 0.3 and 0.1 mg\/kg) of DEX treatment in rat pups on postnatal days 1\u20133 (P1-3) exacerbated HI-induced brain injury on P7 by a glucocorticoid receptor-mediated mechanism. The aggravating effect of neonatal DEX treatment on HI-induced brain injury was correlated with decreased glutamate transporter-1 (GLT-1)-mediated glutamate reuptake. The expression levels of mRNA and protein of GLT-1 were significantly reduced by neonatal DEX treatment. We also found that the administration of \u03b2-lactam antibiotic ceftriaxone increased GLT-1 protein expression and significantly reduced HI-induced brain injury in neonatal DEX-treated rats.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These results suggest that early DEX exposure may lead the neonatal brain to be more vulnerable to subsequent HI injury, which can be ameliorated by administrating ceftriaxone.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1756-6606-6-18","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T00:14:50Z","timestamp":1366244090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Neonatal dexamethasone treatment exacerbates hypoxic-ischemic brain injury"],"prefix":"10.1186","volume":"6","author":[{"given":"Kan-Hsun","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Che-Ming","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Yu","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiung-Chun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuei-Sen","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,18]]},"reference":[{"issue":"5","key":"207_CR1","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1542\/peds.106.5.1070","volume":"106","author":"SK Lee","year":"2000","unstructured":"Lee SK, McMillan DD, Ohlsson A, Pendray M, Synnes A, Whyte R, Chien LY, Sale J: Variations in practice and outcomes in the Canadian NICU network: 1996\u20131997. Pediatrics. 2000, 106 (5): 1070-1079. 10.1542\/peds.106.5.1070.","journal-title":"Pediatrics"},{"issue":"1","key":"207_CR2","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1542\/peds.107.1.e1","volume":"107","author":"JA Lemons","year":"2001","unstructured":"Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, Verter J, Temprosa M, Wright LL, Ehrenkranz RA, Fanaroff AA, Stark A, Carlo W, Tyson JE, Donovan EF, Shankaran S, Stevenson DK: Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics. 2001, 107 (1): E1-10.1542\/peds.107.1.e1.","journal-title":"Pediatrics"},{"issue":"3","key":"207_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.yhbeh.2010.06.007","volume":"59","author":"A Harris","year":"2011","unstructured":"Harris A, Seckl J: Glucocorticoids, prenatal stress and the programming of disease. Horm Behav. 2011, 59 (3): 279-289. 10.1016\/j.yhbeh.2010.06.007.","journal-title":"Horm Behav"},{"issue":"1","key":"207_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1542\/peds.104.1.15","volume":"104","author":"TM O\u2019Shea","year":"1999","unstructured":"O\u2019Shea TM, Kothadia JM, Klinepeter KL, Goldstein DJ, Jackson BG, Weaver RG, Dillard RG: Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics. 1999, 104 (1): 15-21. 10.1542\/peds.104.1.15.","journal-title":"Pediatrics"},{"issue":"3","key":"207_CR5","doi-asserted-by":"publisher","first-page":"F177","DOI":"10.1136\/fn.83.3.F177","volume":"83","author":"ES Shinwell","year":"2000","unstructured":"Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, Bader D, Yurman S, Dolfin T, Kogan A, Dollberg S, Arbel E, Goldberg M, Gur I, Naor N, Sirota L, Mogilner S, Zaritsky A, Barak M, Gottfried E: Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed. 2000, 83 (3): F177-F181. 10.1136\/fn.83.3.F177.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"207_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2431-1-1","volume":"1","author":"KJ Barrington","year":"2001","unstructured":"Barrington KJ: The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr. 2001, 1: 1-10.1186\/1471-2431-1-1.","journal-title":"BMC Pediatr"},{"issue":"13","key":"207_CR7","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1056\/NEJMoa032089","volume":"350","author":"TF Yeh","year":"2004","unstructured":"Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, Tsai CH: Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med. 2004, 350 (13): 1304-1313. 10.1056\/NEJMoa032089.","journal-title":"N Engl J Med"},{"issue":"8","key":"207_CR8","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1096\/fj.02-0333fje","volume":"17","author":"PJ Kamphuis","year":"2003","unstructured":"Kamphuis PJ, Gardoni F, Kamal A, Croiset G, Bakker JM, Cattabeni F, Gispen WH, Van Bel F, Di Luca M, Wiegant VM: Long-lasting effects of neonatal dexamethasone treatment on spatial learning and hippocampal synaptic plasticity: involvement of the NMDA receptor complex. FASEB J. 2003, 17 (8): 911-913.","journal-title":"FASEB J"},{"issue":"6","key":"207_CR9","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/ana.20885","volume":"59","author":"HJ Lin","year":"2006","unstructured":"Lin HJ, Huang CC, Hsu KS: Effects of neonatal dexamethasone treatment on hippocampal synaptic function. Ann Neurol. 2006, 59 (6): 939-951. 10.1002\/ana.20885.","journal-title":"Ann Neurol"},{"issue":"9","key":"207_CR10","doi-asserted-by":"publisher","first-page":"e12806","DOI":"10.1371\/journal.pone.0012806","volume":"5","author":"YC Wang","year":"2010","unstructured":"Wang YC, Huang CC, Hsu KS: The role of growth retardation in lasting effects of neonatal dexamethasone treatment on hippocampal synaptic function. PLoS One. 2010, 5 (9): e12806-10.1371\/journal.pone.0012806.","journal-title":"PLoS One"},{"issue":"3","key":"207_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1055\/s-2000-9293","volume":"17","author":"RC Vannucci","year":"2000","unstructured":"Vannucci RC: Hypoxic-ischemic encephalopathy. Am J Perinatol. 2000, 17 (3): 113-120. 10.1055\/s-2000-9293.","journal-title":"Am J Perinatol"},{"issue":"3","key":"207_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/0014-2999(87)90295-0","volume":"140","author":"JW McDonald","year":"1987","unstructured":"McDonald JW, Silverstein FS, Johnston MV: MK-801 protects the neonatal brain from hypoxic-ischemic damage. Eur J Pharmacol. 1987, 140 (3): 359-361. 10.1016\/0014-2999(87)90295-0.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"207_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/siny.2001.0041","volume":"6","author":"ZS Vexler","year":"2001","unstructured":"Vexler ZS, Ferriero DM: Molecular and biochemical mechanisms of perinatal brain injury. Semin Neonatol. 2001, 6 (2): 99-108. 10.1053\/siny.2001.0041.","journal-title":"Semin Neonatol"},{"issue":"2","key":"207_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0165-5728(95)00152-2","volume":"63","author":"JM Bakker","year":"1995","unstructured":"Bakker JM, Schmidt ED, Kroes H, Kavelaars A, Heijnen CJ, Tilders FJ, Van Rees EP: Effects of short-term dexamethasone treatment during pregnancy on the development of the immune system and the hypothalamo-pituitary adrenal axis in the rat. J Neuroimmunol. 1995, 63 (2): 183-191. 10.1016\/0165-5728(95)00152-2.","journal-title":"J Neuroimmunol"},{"key":"207_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.neuroscience.2011.01.050","volume":"179","author":"Y Feng","year":"2011","unstructured":"Feng Y, Rhodes PG, Bhatt AJ: Dexamethasone pre-treatment protects brain against hypoxic-ischemic injury partially through up-regulation of vascular endothelial growth factor A in neonatal rats. Neuroscience. 2011, 179: 223-232.","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"207_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0006-8993(93)90364-S","volume":"604","author":"UI Tuor","year":"1993","unstructured":"Tuor UI, Simone CS, Arellano R, Tanswell K, Post M: Glucocorticoid prevention of neonatal hypoxic-ischemic damage: role of hyperglycemia and antioxidant enzymes. Brain Res. 1993, 604 (1\u20132): 165-172.","journal-title":"Brain Res"},{"issue":"23","key":"207_CR17","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1056\/NEJM198906083202301","volume":"320","author":"JJ Cummings","year":"1989","unstructured":"Cummings JJ, D\u2019Eugenio DB, Gross SJ: A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med. 1989, 320 (23): 1505-1510. 10.1056\/NEJM198906083202301.","journal-title":"N Engl J Med"},{"issue":"1","key":"207_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0378-3782(79)90022-7","volume":"39","author":"J Dobbing","year":"1979","unstructured":"Dobbing J, Sands J: Comparative aspects of the brain growth spurt. Early Hum Dev. 1979, 39 (1): 79-83.","journal-title":"Early Hum Dev"},{"issue":"9","key":"207_CR19","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1172\/JCI2169","volume":"101","author":"Y Cheng","year":"1998","unstructured":"Cheng Y, Deshmukh M, D\u2019Costa A, Demaro JA, Gidday JM, Shah A, Sun Y, Jacquin MF, Johnson EM, Holtzman DM: Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest. 1998, 101 (9): 1992-1999. 10.1172\/JCI2169.","journal-title":"J Clin Invest"},{"issue":"1","key":"207_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.arcmed.2005.05.014","volume":"37","author":"A Camacho","year":"2006","unstructured":"Camacho A, Massieu L: Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death. Arch Med Res. 2006, 37 (1): 11-18. 10.1016\/j.arcmed.2005.05.014.","journal-title":"Arch Med Res"},{"issue":"1","key":"207_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/1098-1136(200010)32:1<1::AID-GLIA10>3.0.CO;2-W","volume":"32","author":"CM Anderson","year":"2000","unstructured":"Anderson CM, Swanson RA: Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia. 2000, 32 (1): 1-14. 10.1002\/1098-1136(200010)32:1<1::AID-GLIA10>3.0.CO;2-W.","journal-title":"Glia"},{"key":"207_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1423-0127-18-69","volume":"18","author":"PC Lai","year":"2011","unstructured":"Lai PC, Huang YT, Wu CC, Lai CJ, Wang PJ, Chiu TH: Ceftriaxone attenuates hypoxic-ischemic brain injury in neonatal rats. J Biomed Sci. 2011, 18: 69-10.1186\/1423-0127-18-69.","journal-title":"J Biomed Sci"},{"issue":"5","key":"207_CR23","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1111\/j.1471-4159.1986.tb00803.x","volume":"47","author":"FS Silverstein","year":"1986","unstructured":"Silverstein FS, Buchanan K, Johnston MV: Perinatal hypoxia-ischemia disrupts striatal high-affinity [3H]glutamate uptake into synaptosomes. J Neurochem. 1986, 47 (5): 1614-1619. 10.1111\/j.1471-4159.1986.tb00803.x.","journal-title":"J Neurochem"},{"issue":"50","key":"207_CR24","doi-asserted-by":"publisher","first-page":"9159","DOI":"10.1523\/JNEUROSCI.0302-11.2011","volume":"31","author":"M Ghosh","year":"2011","unstructured":"Ghosh M, Yang Y, Rothstein JD, Robinson MB: NF-\u03baB contributes to neuron-dependent induction of glutamate transporter-1 expression in astrocytes. J Neurosci. 2011, 31 (50): 9159-9169.","journal-title":"J Neurosci"},{"issue":"19","key":"207_CR25","doi-asserted-by":"publisher","first-page":"13116","DOI":"10.1074\/jbc.M707697200","volume":"283","author":"SG Lee","year":"2008","unstructured":"Lee SG, Su ZZ, Emdad L, Gupta P, Sarkar D, Borjabad A, Volsky DJ, Fisher PB: Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. J Biol Chem. 2008, 283 (19): 13116-13123. 10.1074\/jbc.M707697200.","journal-title":"J Biol Chem"},{"issue":"4\u20135","key":"207_CR26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0197-0186(03)00023-8","volume":"43","author":"A Rodriguez-Kern","year":"2003","unstructured":"Rodriguez-Kern A, Gegelashvili M, Schousboe A, Zhang J, Sung L, Gegelashvili G: \u03b2-amyloid and brain-derived neurotrophic factor, BDNF, up-regulate the expression of glutamate transporter GLT-1\/EAAT2 via different signaling pathways utilizing transcription factor NF-\u03baB. Neurochem Int. 2003, 43 (4\u20135): 363-370.","journal-title":"Neurochem Int"},{"issue":"5234","key":"207_CR27","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.270.5234.286","volume":"270","author":"N Auphan","year":"1995","unstructured":"Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M: Immunosuppression by glucocorticoids: inhibition of NF-\u03baB activity through induction of I\u03baB synthesis. Science. 1995, 270 (5234): 286-290. 10.1126\/science.270.5234.286.","journal-title":"Science"},{"issue":"5234","key":"207_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1126\/science.270.5234.283","volume":"270","author":"RI Scheinman","year":"1995","unstructured":"Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS: Role of transcriptional activation of I\u03baB-\u03b1 in mediation of immunosuppression by glucocorticoids. Science. 1995, 270 (5234): 283-286. 10.1126\/science.270.5234.283.","journal-title":"Science"},{"issue":"15","key":"207_CR29","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1093\/emboj\/16.15.4698","volume":"16","author":"S Heck","year":"1997","unstructured":"Heck S, Bender K, Kullmann M, G\u00f6ttlicher M, Herrlich P, Cato AC: I\u03baB-\u03b1 -independent downregulation of NF-\u03baB activity by glucocorticoid receptor. EMBO J. 1997, 16 (15): 4698-4707. 10.1093\/emboj\/16.15.4698.","journal-title":"EMBO J"},{"issue":"2","key":"207_CR30","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1073\/pnas.91.2.752","volume":"91","author":"A Ray","year":"1994","unstructured":"Ray A, Prefontaine KE: Physical association and functional antagonism between the p65 subunit of transcription factor NF-\u03baB and the glucocorticoid receptor. Proc Natl Acad Sci USA. 1994, 91 (2): 752-756. 10.1073\/pnas.91.2.752.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"41","key":"207_CR31","doi-asserted-by":"publisher","first-page":"34924","DOI":"10.1074\/jbc.M502581200","volume":"280","author":"J Zschocke","year":"2005","unstructured":"Zschocke J, Bayatti N, Clement AM, Witan H, Figiel M, Engele J, Behl C: Differential promotion of glutamate transporter expression and function by glucocorticoids in astrocytes from various brain regions. J Biol Chem. 2005, 280 (41): 34924-34932. 10.1074\/jbc.M502581200.","journal-title":"J Biol Chem"},{"issue":"7021","key":"207_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nature03180","volume":"433","author":"JD Rothstein","year":"2005","unstructured":"Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, Vidensky S, Chung DS, Toan SV, Bruijn LI, Su ZZ, Gupta P, Fisher PB: \u03b2-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature. 2005, 433 (7021): 73-77. 10.1038\/nature03180.","journal-title":"Nature"},{"issue":"10","key":"207_CR33","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1002\/jcp.22609","volume":"226","author":"K Kim","year":"2011","unstructured":"Kim K, Lee SG, Kegelman TP, Su ZZ, Das SK, Dash R, Dasgupta S, Barral PM, Hedvat M, Diaz P, Reed JC, Stebbins JL, Pellecchia M, Sarkar D, Fisher PB: Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J Cell Physiol. 2011, 226 (10): 2484-2493. 10.1002\/jcp.22609.","journal-title":"J Cell Physiol"},{"issue":"6","key":"207_CR34","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1203\/00006450-199106010-00008","volume":"29","author":"JD Barks","year":"1991","unstructured":"Barks JD, Post M, Tuor UI: Dexamethasone prevents hypoxic-ischemic brain damage in the neonatal rat. Pediatr Res. 1991, 29 (6): 558-563. 10.1203\/00006450-199106010-00008.","journal-title":"Pediatr Res"},{"issue":"2","key":"207_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.pneurobio.2012.05.010","volume":"98","author":"Y Li","year":"2012","unstructured":"Li Y, Gonzalez P, Zhang L: Fetal stress and programming of hypoxic\/ischemic-sensitive phenotype in the neonatal brain: mechanisms and possible interventions. Prog Neurobiol. 2012, 98 (2): 145-165. 10.1016\/j.pneurobio.2012.05.010.","journal-title":"Prog Neurobiol"},{"issue":"1","key":"207_CR36","first-page":"149","volume":"58","author":"VR Amberger","year":"1998","unstructured":"Amberger VR, Hensel T, Ogata N, Schwab ME: Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity. Cancer Res. 1998, 58 (1): 149-158.","journal-title":"Cancer Res"},{"issue":"4","key":"207_CR37","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0896-6273(03)00021-7","volume":"37","author":"D Saal","year":"2003","unstructured":"Saal D, Dong Y, Bonci A, Malenka RC: Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron. 2003, 37 (4): 577-582. 10.1016\/S0896-6273(03)00021-7.","journal-title":"Neuron"},{"issue":"1","key":"207_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/glia.440090107","volume":"9","author":"Y Nakamura","year":"1993","unstructured":"Nakamura Y, Iga K, Shibata T, Shudo M, Kataoka K: Glial plasmalemmal vesicles: a subcellular fraction from rat hippocampal homogenate distinct from synaptosomes. Glia. 1993, 9 (1): 48-56. 10.1002\/glia.440090107.","journal-title":"Glia"},{"issue":"7","key":"207_CR39","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/npp.2010.33","volume":"35","author":"CC Chen","year":"2010","unstructured":"Chen CC, Yang CH, Huang CC, Hsu KS: Acute stress impairs hippocampal mossy fiber-CA3 long-term potentiation by enhancing cAMP-specific phosphodiesterase 4 activity. Neuropsychopharmacol. 2010, 35 (7): 1605-1617. 10.1038\/npp.2010.33.","journal-title":"Neuropsychopharmacol"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-6606-6-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T23:31:22Z","timestamp":1630539082000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/1756-6606-6-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,18]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["207"],"URL":"https:\/\/doi.org\/10.1186\/1756-6606-6-18","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,18]]},"assertion":[{"value":"16 November 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"18"}}